Blood test could be key to picking winning leukemia treatment
NCT ID NCT07060001
Summary
This study is testing whether a new blood test can help doctors choose the most effective chemotherapy for adults newly diagnosed with acute myeloid leukemia (AML). About 112 patients will receive one of two standard chemotherapy types, and the blood test will check for tiny amounts of leftover cancer after treatment to guide next steps. The main goal is to see if using this test leads to longer remissions and better survival by helping pick the right treatment for each person.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA (AML) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Houston Methodist Neal Cancer Center
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.